KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Asset Writedowns and Impairment (2016 - 2019)

Historic Asset Writedowns and Impairment for Quest Diagnostics (DGX) over the last 11 years, with Q4 2019 value amounting to $2.0 million.

  • Quest Diagnostics' Asset Writedowns and Impairment fell 5000.0% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.0 million, marking a year-over-year increase of 8333.33%. This contributed to the annual value of $5.0 million for FY2024, which is 40000.0% up from last year.
  • Quest Diagnostics' Asset Writedowns and Impairment amounted to $2.0 million in Q4 2019, which was down 5000.0% from $4.0 million recorded in Q3 2019.
  • In the past 5 years, Quest Diagnostics' Asset Writedowns and Impairment registered a high of $86.0 million during Q1 2016, and its lowest value of -$235.0 million during Q4 2016.
  • In the last 5 years, Quest Diagnostics' Asset Writedowns and Impairment had a median value of $3.5 million in 2017 and averaged $16.4 million.
  • In the last 5 years, Quest Diagnostics' Asset Writedowns and Impairment crashed by 46153.85% in 2016 and then surged by 13333.33% in 2019.
  • Over the past 5 years, Quest Diagnostics' Asset Writedowns and Impairment (Quarter) stood at $65.0 million in 2015, then crashed by 461.54% to -$235.0 million in 2016, then soared by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then tumbled by 50.0% to $2.0 million in 2019.
  • Its last three reported values are $2.0 million in Q4 2019, $4.0 million for Q3 2019, and $1.0 million during Q2 2019.